ACE2 and COVID-19: Altogether, this suggests that ACE2 targeting by SARS-CoV-2 is not just the entry route of the viral infection but may trigger a major mechanism of COVID-19 severity by promoting tissue RAS dysregulation, which induces a hyperinflammatory state in several organs, leading to lung injury, hematological alterations, and immunological dysregulation.